Evidence map›Paper›PMID 41809499›Full record

ArticleReviews of modern physics

FLASH: New intersection of physics, chemistry, biology, and cancer medicine.

Marie-Catherine Vozenin, Billy W Loo, Sami Tantawi, Peter G Maxim, Douglas R Spitz, Claude Bailat, Charles L Limoli

Abstract read
In one paragraph

Article in Reviews of modern physics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Musculoskeletal and Marrow Sparing With Proton FLASH Radiation Therapy in Juvenile Mice.International journal of radiation oncology, biology, physics · 2026
    Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Microenvironmental remodeling in FLASH radiotherapy.Frontiers in cell and developmental biology · 2026
    Review
  17. Article
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Marie-Catherine VozeninRadiotherapy and Radiobiology Sector, Radiation Therapy Service, University Hospital of Geneva and Laboratory of Innovation in Radiobiology Applied to Radiotherapy (LiRR), University of Geneva, Geneva, Switzerland.ORCID https://orcid.org/0000-0002-2109-8073
Billy W LooDepartment of Radiation Oncology and Stanford Cancer Institute, Stanford University School of Medicine, Stanford, California 94305, USA.ORCID https://orcid.org/0000-0002-2521-0544
Sami TantawiSLAC National Accelerator Laboratory, Menlo Park, California 94025, USA.
Peter G MaximDepartment of Radiation Oncology, University of California, Irvine, Irvine, California 92697-2695, USA.ORCID https://orcid.org/0000-0002-8244-2042
Douglas R SpitzFree Radical and Radiation Biology Program, Department of Radiation Oncology, University of Iowa, Iowa City, Iowa 52242, USA.ORCID https://orcid.org/0000-0002-1254-8765
Claude BailatInstitute of Radiation Physics/CHUV, Lausanne University Hospital, Switzerland.
Charles L LimoliDepartment of Radiation Oncology, University of California, Irvine, California 92697-2695, USA.ORCID https://orcid.org/0000-0002-1321-4142

Funding

Project 4: Mechanistic Basics of FLASH Effect: Role of O2P01CA244091 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI LIMOLI, CHARLES · 2020 to 2024
$9.6M
Research Supplements to Promote Diversity in Health-Related Research: Preclinical optimization of ultra-high dose rate (FLASH) radiotherapy parameters for translational relevanceR01CA266673 · NCI · UNIVERSITY OF TX MD ANDERSON CAN CTR · PI SCHUELER, EMIL · 2022 to 2025
$3.5M
Effects of FLASH Radiation on Cancer and the Immune ResponseR01CA233958 · NCI · STANFORD UNIVERSITY · PI ENGLEMAN, EDGAR G., LOO, BILLY W · 2019 to 2024
$2.7M
Improving pediatric brain tumor treatments using FLASH radiotherapyR01CA254892 · NCI · UNIVERSITY OF CALIFORNIA-IRVINE · PI Charles Limoli · 2021 to 2026
$2.5M
Practical Implementation of an Ultra-rapid FLASH Radiation Therapy Linac BeamlineR44CA217607 · NCI · TIBARAY, INC. · PI BHARADWAJ, VINOD, GRAVES, EDWARD E. · 2019 to 2021
$2.0M
NCI NIH HHS P01 CA244091NCI NIH HHS R01 CA233958NCI NIH HHS R01 CA254892NCI NIH HHS R01 CA266673NCI NIH HHS R44 CA217607
6 · The paper itself

Abstract

Ultrahigh dose rate, FLASH radiotherapy has emerged as one of the most promising innovations over the past decade in the field of radiation oncology, with the potential to eradicate radiation resistant primary tumors and improve the therapeutic outcome for cancer patients. FLASH is based on delivering radiation doses at ultrahigh dose rates (UHDR; >40 Gy/s), more than 1000 times faster than irradiation at conventional dose rates (CONV). The experimental evidence demonstrating the differential effect of dose rate modulation on tumors and normal tissue is reviewed. Preclinical data consistently show that the antitumor efficacy of cytotoxic doses is not dependent on dose rate, but in normal tissues UHDR significantly reduces normal tissue toxicities compared to CONV, as observed

Identifiers

PMID41809499
PMCPMC12971056

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.